|
RSL24D1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.33586541407294E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.90558721316847E-14 |
| Normal-vs-Stage2 |
6.21469999999569E-05 |
| Normal-vs-Stage3 |
5.389200E-04 |
| Normal-vs-Stage4 |
4.759800E-03 |
| Stage1-vs-Stage2 |
9.754800E-01 |
| Stage1-vs-Stage3 |
5.696400E-03 |
| Stage1-vs-Stage4 |
9.984400E-04 |
| Stage2-vs-Stage3 |
4.935700E-02 |
| Stage2-vs-Stage4 |
3.334200E-02 |
| Stage3-vs-Stage4 |
6.550400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92823534916897E-12 |
| Normal-vs-AfricanAmerican |
9.900300E-03 |
| Normal-vs-Asian |
8.270200E-01 |
| Caucasian-vs-AfricanAmerican |
5.301800E-02 |
| Caucasian-vs-Asian |
1.026980E-01 |
| AfricanAmerican-vs-Asian |
2.333600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68087765928249E-13 |
| Normal-vs-Female |
4.70910000005542E-06 |
| Male-vs-Female |
2.268200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.119000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.42769995825631E-09 |
| Normal-vs-Age(61-80Yrs) |
7.84380005391938E-10 |
| Normal-vs-Age(81-100Yrs) |
2.356300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.479600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.911600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.592600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.436600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.345400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.542600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.316400E-03 |
| Normal-vs-Grade 2 |
3.33066907387547E-16 |
| Normal-vs-Grade 3 |
8.07429999971632E-07 |
| Normal-vs-Grade 4 |
7.944600E-01 |
| Grade 1-vs-Grade 2 |
7.666400E-01 |
| Grade 1-vs-Grade 3 |
2.475800E-01 |
| Grade 1-vs-Grade 4 |
1.684460E-03 |
| Grade 2-vs-Grade 3 |
1.002400E-04 |
| Grade 2-vs-Grade 4 |
1.49179557595858E-11 |
| Grade 3-vs-Grade 4 |
2.035900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.956840E-03 |
| ccA subtype-vs-ccB subtype |
1.69010000439229E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.07289998896709E-09 |
| Normal-vs-N1 |
8.082800E-01 |
| N0-vs-N1 |
7.847300E-04 |
|
|
